MICHELIN (CGDE) (ML.PA)

FR001400AJ45 - Common Stock

27.47  -0.07 (-0.25%)


Fundamental Rating

6

Taking everything into account, ML scores 6 out of 10 in our fundamental rating. ML was compared to 14 industry peers in the Automobile Components industry. ML has a great profitability rating, but there are some minor concerns on its financial health. ML is not valued too expensively and it also shows a decent growth rate.




Profitability

Profitability Rating

7

ML has a Return On Assets of 5.66%. This is amongst the best returns in the industry. The industry average is 3.39%. ML outperforms 88% of its industry peers.
ML has a Return On Equity of 11.69%. This is better than the industry average of 9.58%.

ML has a Profit Margin of 7.00%. This is amongst the best returns in the industry. The industry average is 1.96%. ML outperforms 100% of its industry peers.
ML has a Piotroski-F score of 6.00. This indicates an average health and profitability for ML.
VS Industry

ROA (5.66%) VS Industry: 88% outperformed.

0.31
6.20

ROE (11.69%) VS Industry: 66% outperformed.

0.77
14.85

Profit Margin (7%) VS Industry: 100% outperformed.

0.26
7.00

Valuation

Valuation Rating

5

With a Price/Earnings Ratio of 9.78, the valuation of ML can be described as very reasonable.
The Forward Price/Earnings Ratio of 8.85 indicates a rather cheap valuation of ML.
ML's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ML's Price/Earning Ratio is in line with the industry average which is at 13.76.

When comparing the current price to the book value of ML, we can conclude it is valued correctly. It is trading at 1.15 times its book value.
Compared to an average industry Enterprise Value to EBITDA ratio of 4.89, ML is valued in line with its industry peers.
Compared to an average industry price book ratio of 0.97, ML is valued more expensive than its industry peers.
VS Industry

Price/Earnings (9.78) VS Industry: 55% outperformed.

37.96
7.05

Price/Book (1.15) VS Industry: 38% outperformed.

2.84
0.06

Enterprise Value/ EBITDA (4.89) VS Industry: 46% outperformed.

12.56
2.73

Growth

Growth Rating

5

The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue has grown by 20.15% in the past year. This is a very strong growth!
ML shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 9.77%.
Measured over the past 5 years, ML shows a small growth in Earnings Per Share. The EPS has been growing by 3.66% on average per year.

The Earnings Per Share is expected to grow by 7.63% on average over the next 5 years.
The Revenue has been growing slightly by 5.42% on average over the past 5 years.
The Revenue is expected to grow by 0.75% on average over the next 5 years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS3.66% 5.18% 9.77% 10.51% 9.49% 9.02% 7.63%
Revenue5.42% 5.81% 20.15% 3.51% 3.04% 2.85% 0.75%

Health

Health Rating

6

ML is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.64.
The Quick Ratio of ML is much better than the industry average of 0.96.
The Debt to Equity ratio of ML is way better than the industry averages.
When comparing the Altman-Z score to an average industry score of 2.16, ML is in better financial health than the average industry peer.

ML has a Current Ratio of 1.67. This is a normal value and indicates that ML is financially healthy and should not expect problems in meeting its short term obligations.
ML has an Altman-Z score of 2.52. This is not the best score and indicates that ML is in the grey zone with still only limited risk for bankruptcy at the moment.
The Piotroski-F score of ML is 6.00. This is a neutral score and indicates average health and profitability for ML.
A Quick Ratio of 0.97 indicates that ML may have some problems paying its short term obligations.
VS Industry

Debt/Equity (0.31) VS Industry: 76% outperformed.

2.86
0.03

Quick Ratio (0.97) VS Industry: 61% outperformed.

0.56
1.98

Current Ratio (1.67) VS Industry: 69% outperformed.

0.79
2.76

Altman-Z (2.52) VS Industry: 76% outperformed.

1.03
3.56

Dividend

Dividend Rating

9

ML has a Yearly Dividend Yield of 4.60%, which is a nice return.
Compared to an average industry Dividend Yield of 2.51, ML pays a bit more dividend than its industry peers.
ML's Dividend Yield is rather good when compared to the S&P500 average which is at 2.72.

On average, the dividend of ML grows each year by 6.73%, which is quite nice.
ML's earnings are growing more than its dividend. This makes the dividend growth sustainable.
40.13% of the earnings are spent on dividend by ML. This is a bit on the high side, but may be sustainable.
VS Industry

Dividend Yield (4.6%) VS Industry: 77% outperformed.

0.65
7.61

MICHELIN (CGDE)

EPA:ML (5/29/2023, 7:00:00 PM)

27.47

-0.07 (-0.25%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.62B
Analysts77.14
Price Target33.35 (21.41%)
Dividend
Industry RankSector Rank
Dividend Yield 4.6%
Dividend Growth(5Y)6.73%
DP40.13%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-10.88%
Min EPS beat(2)-10.88%
Max EPS beat(2)-10.88%
EPS beat(4)N/A
Avg EPS beat(4)-17.09%
Min EPS beat(4)-23.29%
Max EPS beat(4)-10.88%
Revenue beat(2)1
Avg Revenue beat(2)0.23%
Min Revenue beat(2)0.23%
Max Revenue beat(2)0.23%
Revenue beat(4)1
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)0.23%
PT rev (1m)-0.51%
PT rev (3m)1.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 9.78
Fwd PE 8.85
P/S 0.69
P/FCF N/A
P/OCF 10.16
P/B 1.15
P/tB 1.52
EV/EBITDA 4.89
EPS(TTM)2.81
EY10.23%
EPS(NY)3.11
Fwd EY11.3%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)2.7
OCFY9.84%
SpS40.04
BVpS23.96
TBVpS18.03
PEG (NY)0.93
PEG (5Y)2.67
Profitability
Industry RankSector Rank
ROA 5.66%
ROE 11.69%
ROIC 8.74%
ROICexc 9.67%
ROICexgc 11.71%
OM 10.95%
PM 7%
GM 26.37%
ROICexgc(3y)11.04%
ROICexcg growth 3Y-0.6%
ROICexcg growth 5Y-1.59%
ROICexc(3y)8.97%
ROICexc growth 3Y0.37%
ROICexc growth 5Y-3.19%
OM growth 3Y-4.17%
OM growth 5Y-2.6%
PM growth 3Y-0.98%
PM growth 5Y-1.87%
GM growth 3Y-3.5%
GM growth 5Y-4.12%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 1.59
Cap/Depr 114.74%
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 0.97
Altman-Z 2.52
F-Score6
WACC7.04%
ROIC/WACC1.66
Cap/Depr(3y)94.24%
Cap/Depr(5y)101.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y9.77%
EPS 3Y5.18%
EPS 5Y3.66%
EPS growth Q2Q44.49%
EPS Next Y10.51%
EPS Next 2Y9.49%
EPS Next 3Y9.02%
EPS Next 5Y7.63%
Revenue growth 1Y20.15%
Revenue growth 3Y5.81%
Revenue growth 5Y5.42%
Revenue growth Q2Q21.41%
Revenue Next Year3.51%
Revenue Next 2Y3.04%
Revenue Next 3Y2.85%
Revenue Next 5Y0.75%
EBIT growth 1Y5.07%
EBIT growth 3Y1.4%
EBIT growth 5Y2.68%
EBIT Next Year61.97%
EBIT Next 3Y21.55%
EBIT Next 5Y16.23%
FCF growth 1Y-117.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.55%
OCF growth 3Y-16.53%
OCF growth 5Y-6.77%
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext